Welcome to Qatar Biobank

Qatar Biobank is a platform that will make vital health research possible through its collection of samples and information on health and lifestyle from large numbers of members of the Qatari population. Qatar Biobank, Qatar’s long-term medical health initiative, was created to give Qatar’s people better chances of avoiding serious illnesses, and to promote better health for our future generations.

Participating

Participating

You are being invited to take part in Qatar Biobank, Qatar’s long-term medical health initiative for Qatar’s population. To help you decide whether to contribute, here is some information on Qatar Biobank and what taking part involves.

Research

Health Supplement-The Edge.jpg

Qatar Biobank will make it possible for scientists to conduct research to address some of the greatest health challenges facing Qatar and the region, including cardiovascular disease, obesity, diabetes, and cancer.

Qatar Genome

Thumbnail - Genome - noshadow.png

Qatar Genome Programme is an initiative that aims to use the latest DNA sequencing technology to establish a genome map of the local population.

Latest News

Events

Past Events

Dr Hanan Al Kuwari

QATAR BIOBANK INAUGURAL CONFERENCE SHINES LIGHT ON NEED FOR REGIONAL RESEARCH COLLABORATION

16/02/15

Doha, 16 February 2015: The importance of regional medical research collaboration was the focus of the ‘Biobanking in the Context of Personalised Healthcare’ conference, hosted by Qatar Biobank, a member of Qatar Foundation for Education, Science and Community Development, in Doha last week.

Read More About the event: QATAR BIOBANK INAUGURAL CONFERENCE SHINES LIGHT ON NEED FOR REGIONAL RESEARCH COLLABORATION

Image-1

QATAR BIOBANK RELEASES RESULTS OF PILOT PHASE

28/01/15

Doha, 28 January 2015: Qatar Biobank, a member of Qatar Foundation for Education, Science and Community Development (QF), has released the findings of its two year operational pilot phase, which reveal that 76 per cent of male and 70 per cent of female participants, from a sample of 1,200 are either overweight or obese. It also reveals that 52.7 per cent of the male participants and 31.7 per cent of female participants recorded pre-hypertensive (normal-high blood pressure levels) or hypertensive.

Read More About the event: QATAR BIOBANK RELEASES RESULTS OF PILOT PHASE

Partners

Qatar Foundation Ministry of Public Health
Hamad Medical Corporation

Certifications

BSI-Assurance-Mark-ISO-9001-Red.png BSI-Assurance-Mark-ISO-27001-Red.png